Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

viibryd (vilazodone)

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    viibryd (vilazodone)

    I have lupus so experience side effects and sensitivities to SSRI's and most other antidepressants, not to mention other "mood stabilizers" etc. (I have tried them all over the years :P) I have postpartum depression and severe anxiety and would like to try vilazodone (Viibryd). Any news on if it is safe for breastfeeding?
    Tags: None
  • #2
    Lavinialuna:

    Vilazodone is just another SSRI with partial activity on another serotonin receptor site. We have absolutley no data on its transfer into human milk. However, thus far, we don't have any SSRI that transfers into milk at levels greater than about 8% of the maternal dose. If I were to guess, I'd suggest this product enters milk modestly as it has a 99% protein binding.

    But I can't really advise you that its totally safe for a breastfed infant, but I imagine its quite similar to all the rest of the SSRI family, which are quite safe for breastfeeding infants.

    Tom Hale Ph.d.

    Comment

    Previous template Next
    Working...
    X